Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for 08340_FLUKA

    Client Email Product

    08340_FLUKA

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    9
    US DMFs Filed

    US DMFs Filed

    6
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    2
    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    3
    API REF. PRICE (USD / KG)
    31,545

    API Market Place

    3
    INTERMEDIATES
    2
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    3
    Europe

    Europe

    8
    Canada

    Canada

    2
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    1.00

    Annual Reports

    0

    FDF Market Place

    1
    EXCIPIENTS
    23
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    7

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    15
    REF STANDARD

    EDQM

    0

    USP

    3

    JP

    0

    Other Listed Suppliers

    3
    SERVICES

    0

    Full View ScreenFull Screen View
    Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion U.S. Patent
    Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion U.S. Patent

    https://www.globenewswire.com/news-release/2022/09/06/2510637/0/en/Biofrontera-Inc-Announces-Notice-of-Allowance-for-Nanoemulsion-Composition-of-Matter-U-S-Patent.html

    GLOBENEWSWIRE
    06 Sep 2022
    Share Share
    Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK
    Sun Pharma presents clinical insights of ODOMZO and LEVULAN KERASTICK

    https://www.expresspharma.in/latest-updates/sun-pharma-presents-clinical-insights-of-odomzo-and-levulan-kerastick-blu-u-data-for-skin-cancer-treatment/

    EXPRESS PHARMA
    12 Jun 2020
    Share Share
    Sun Pharma Plans to Present Clinical Insights from 25 Data Abstracts
    Sun Pharma Plans to Present Clinical Insights from 25 Data Abstracts

    https://www.prnewswire.com/news-releases/sun-pharma-plans-to-present-clinical-insights-from-25-data-abstracts-across-its-dermatology-portfolio-at-the-2020-aad-virtual-meeting-experience-301074129.html

    PRNEWSWIRE
    10 Jun 2020
    Share Share
    Alnylam Announces Approval of GIVLAARI® (givosiran) in the European Union
    Alnylam Announces Approval of GIVLAARI® (givosiran) in the European Union

    https://www.businesswire.com/news/home/20200303005205/en/Alnylam-Announces-Approval-GIVLAARI%C2%AE-givosiran-European-Union/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    03 Mar 2020
    Share Share
    ‘Groundbreaking’ new brain cancer treatment available
    ‘Groundbreaking’ new brain cancer treatment available

    http://www.pharmatimes.com/news/groundbreaking_new_brain_cancer_treatment_available_1287732

    Anna Smith PHARMA TIMES
    13 May 2019
    Share Share
    Alnylam shores up enthusiasm for givosiran with early dataset
    Alnylam shores up enthusiasm for givosiran with early dataset

    https://endpts.com/alnylam-shores-up-enthusiasm-for-givosiran-with-early-dataset-ahead-of-crucial-phiii-readout/

    Amber Tong ENDPTS
    07 Feb 2019
    Share Share
    Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
    Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug

    https://www.xconomy.com/boston/2018/10/15/alnylam-wont-seek-quick-fda-nod-for-second-rnai-drug/

    Ben Fidler XCONOMY
    16 Oct 2018
    Share Share
    Sun Pharma's subsidiary files patent infringement suit against Biofrontera
    Sun Pharma's subsidiary files patent infringement suit against Biofrontera

    https://health.economictimes.indiatimes.com/news/pharma/sun-pharmas-subsidiary-files-patent-infringement-suit-against-german-drug-maker-biofrontera/64954247

    Divya Rajagopal ECONOMIC TIMES
    12 Jul 2018
    Share Share
    NICE backs use of dye for brain tumour removal
    NICE backs use of dye for brain tumour removal

    http://www.pharmatimes.com/news/nice_backs_use_of_dye_for_brain_tumour_removal_1243902

    Selina McKee PHARMA TIMES
    11 Jul 2018
    Share Share
    Biofrontera files for IPO to run skin cancer clinical trials
    Biofrontera files for IPO to run skin cancer clinical trials

    https://www.fiercebiotech.com/biotech/biofrontera-files-for-ipo-to-run-skin-cancer-clinical-trials

    Nick P. Taylor FIERCE BIOTECH
    15 Jan 2018
    Share Share
    Chugai Pharma to market SBI Pharma's Alaglio Granule 1.5g in Japan
    Chugai Pharma to market SBI Pharma's Alaglio Granule 1.5g in Japan

    http://www.pharmabiz.com/NewsDetails.aspx?aid=100866&sid=2

    PHARMABIZ
    14 Mar 2017
    Share Share
    How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US
    How Top Indian Drug Makers Like Sun, Glenmark are Building Business in the US

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/how-top-indian-drug-makers-like-sun-pharma-glenmark-are-building-a-brands-business-in-the-us/articleshow/56382828.cms

    Vikas Dandekar ECONOMIC TIMES
    07 Jan 2017
    Share Share
    Biofrontera Pharma's Ameluz (Aminolevulinic Acid Hydrochloride) approved in US for actinic keratosis
    Biofrontera Pharma's Ameluz (Aminolevulinic Acid Hydrochloride) approved in US for actinic keratosis

    https://www.pharmacompass.com/pdf/news/biofrontera-pharmas-ameluz-aminolevulinic-acid-hydrochloride-approved-in-us-for-actinic-keratosis-1463053180.pdf

    FDA
    10 May 2016
    Share Share
    NZ gets drug that glows brain tumour
    NZ gets drug that glows brain tumour

    http://www.biospectrumasia.com/biospectrum/news/222435/nz-drug-glows-brain-tumour

    BioSpectrum Bureau BIOSPECTRUM ASIA
    21 Sep 2015
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Midas Aminolevulinic Acid HCl

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search